Popat Ketul C, Leoni Lara, Grimes Craig A, Desai Tejal A
Department of Physiology/Division of Bioengineering, University of California, 1700-4th Street, Box 2520, San Francisco, CA 94143-2520, USA.
Biomaterials. 2007 Jul;28(21):3188-97. doi: 10.1016/j.biomaterials.2007.03.020. Epub 2007 Mar 21.
A goal of current orthopedic biomaterials research is to design implants that induce controlled, guided, and rapid healing. In addition to acceleration of normal wound healing phenomena, these implants should result in the formation of a characteristic interfacial layer with adequate biomechanical properties. To achieve these goals, however, a better understanding of events at the bone-material interface is needed, as well as the development of new materials and approaches that promote osseointegration. Using anodization, titania interfaces can be fabricated with controlled nanoarchitecture. This study demonstrates the ability of these surfaces to promote osteoblast differentiation and matrix production, and enhance short- and long-term osseointegration in vitro. Titania nanotubular surfaces were fabricated using an anodization technique. Marrow stromal cells (MSCs) were isolated from male Lewis rats and seeded on these surfaces along with control surfaces. The interaction of cells with these surfaces was investigated in terms of their ability to adhere, proliferate and differentiate on them. The experiments were repeated three times with cells from different cultures. All the results were analyzed using analysis of variance (ANOVA). Statistical significance was considered at p<0.05. Furthermore, in vivo biocompatibility was assessed by implanting surfaces subcutaneously in male Lewis rat and performing histological analysis after 4 weeks. Our results indicate that the nanotubular titania surfaces provide a favorable template for the growth and maintenance of bone cells. The cells cultured on nanotubular surfaces showed higher adhesion, proliferation, ALP activity and bone matrix deposition compared to those grown on flat titanium surfaces. In vivo biocompatibility results suggest that nanotubular titania does not cause chronic inflammation or fibrosis. The fabrication routes of titania nano-architectures are flexible and cost-effective, enabling realization of desired platform topologies on existing non-planar orthopedic implants.
当前骨科生物材料研究的一个目标是设计出能诱导可控、定向且快速愈合的植入物。除了加速正常伤口愈合现象外,这些植入物还应形成具有足够生物力学性能的特征性界面层。然而,要实现这些目标,需要更好地了解骨 - 材料界面处发生的事件,以及开发促进骨整合的新材料和方法。通过阳极氧化,可以制造出具有可控纳米结构的二氧化钛界面。本研究证明了这些表面促进成骨细胞分化和基质产生以及增强体外短期和长期骨整合的能力。采用阳极氧化技术制备了二氧化钛纳米管表面。从雄性Lewis大鼠中分离出骨髓基质细胞(MSC),并将其接种在这些表面以及对照表面上。从细胞在这些表面上的黏附、增殖和分化能力方面研究了细胞与这些表面的相互作用。用来自不同培养物的细胞将实验重复进行三次。所有结果均使用方差分析(ANOVA)进行分析。当p<0.05时认为具有统计学意义。此外,通过将表面皮下植入雄性Lewis大鼠体内并在4周后进行组织学分析来评估体内生物相容性。我们的结果表明,纳米管二氧化钛表面为骨细胞的生长和维持提供了有利的模板。与在平坦钛表面上生长的细胞相比,在纳米管表面上培养的细胞表现出更高的黏附、增殖、碱性磷酸酶活性和骨基质沉积。体内生物相容性结果表明,纳米管二氧化钛不会引起慢性炎症或纤维化。二氧化钛纳米结构的制造路线灵活且具有成本效益,能够在现有的非平面骨科植入物上实现所需的平台拓扑结构。